Efficacy and safety of 10 day treatment with the CRTh2 antagonist QAV680 evaluated in patients with allergic rhinitis in an environmental exposure chamber

V. J. Erpenbeck, A. M. Salapatek, P. Patel, J. Sanni, G. Dubois, P. Zhou, S. Perry, M. Larbig (Basel, Switzerland; Toronto, Canada; Horsham, West Sussex, United Kingdom)

Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Session: Allergy and asthma: novel findings based on human cell biology
Session type: Thematic Poster Session
Number: 4075
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. J. Erpenbeck, A. M. Salapatek, P. Patel, J. Sanni, G. Dubois, P. Zhou, S. Perry, M. Larbig (Basel, Switzerland; Toronto, Canada; Horsham, West Sussex, United Kingdom). Efficacy and safety of 10 day treatment with the CRTh2 antagonist QAV680 evaluated in patients with allergic rhinitis in an environmental exposure chamber. Eur Respir J 2014; 44: Suppl. 58, 4075

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014


Comparative efficacy of different groups of drugs for the treatment of bronchial asthma in combination with allergic rhinitis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


Therapeutic effectpredictors during sublingual immunotherapy for Japanese seasonal allergic rhinitis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Effects of airborne pollen levels on drug consumption for seasonal allergic rhinoconjunctivitis: A ten-year French study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Intranasal GSK2245035 induces prolonged reductions in nasal responsiveness to allergen
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


Distribution of mast cells and their interactions with nerve in allergic rhinitis
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

Efficacy and safety of fevipiprant (QAW039) in patients with atopic asthma uncontrolled on low-dose ICS therapy
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016


Allergic rhinitis does it have an impact on controller asthma therapy choice
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014


LATE-BREAKING ABSTRACT: Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting the allergen-induced early asthmatic response
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014


Predictors factors for asthma in patients with rhinitis
Source: International Congress 2014 – Clinical allergy
Year: 2014


Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


Clinical effectiveness of anti-IgE therapy in allergic severe asthma
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

Unexpected severe systemic allergic reaction after hymenoptera sting in well controlled asthma during treatment with omalizumab
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Should patients with mild asthma be excluded from allergic rhinitis drug trials?
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015


Clinical characteristics of seasonal rhinitis and co-existence with asthma
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016


25(OH) vitamin D levels in pediatric asthma and allergic rhinitis
Source: International Congress 2014 – More paediatric asthma
Year: 2014